{"id":30057,"date":"2019-12-14T01:00:00","date_gmt":"2019-12-14T01:00:00","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=30057"},"modified":"2019-12-14T01:00:00","modified_gmt":"2019-12-14T01:00:00","slug":"cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/","title":{"rendered":"Cardiology MCQ &#8211; Treatment of transthyretin amyloid cardiomyopathy &#8211; Answer"},"content":{"rendered":"<p><iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/b9x0oYWSyV8\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\"><\/iframe><\/p>\n<h2><span style=\"color: #008000;\">Cardiology MCQ &#8211; Treatment of transthyretin amyloid cardiomyopathy &#8211; Answer<\/span><\/h2>\n<p><span style=\"color: #0000ff;\"><strong>Recently developed pharmacotherapy which has been shown to halt and reverse the progression of transthyretin amyloid cardiomyopathy:<\/strong><\/span><\/p>\n<p><span style=\"color: #008000;\"><strong>Correct answer: 2. Tafamidis&nbsp;<\/strong><\/span><\/p>\n<p>Transthyretin amyloid cardiomyopathy is due to transthyretin amyloid fibril deposition in the myocardium. Tafamidis acts by binding to transthyretin and prevents tetramer dissociation, thus preventing amyloid formation.<\/p>\n<p><a href=\"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy\/\"><strong>Back to question<\/strong><\/a><\/p>\n<h3><span style=\"color: #0000ff;\">Reference<\/span><\/h3>\n<ol>\n<li>Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30145929\/\">Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy<\/a>. N Engl J Med. 2018 Sep 13;379(11):1007-1016.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Cardiology MCQ &#8211; Treatment of transthyretin amyloid cardiomyopathy &#8211; Answer Recently developed pharmacotherapy which has been shown to halt and reverse the progression of transthyretin amyloid cardiomyopathy: Correct answer: 2. Tafamidis&nbsp; Transthyretin amyloid cardiomyopathy is due to transthyretin amyloid fibril deposition in the myocardium. Tafamidis acts by binding to transthyretin and prevents tetramer dissociation, thus [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":34370,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[3,5],"tags":[],"class_list":["post-30057","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cardiology-mcq","category-dm-dnb-cardiology-entrance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cardiology MCQ - Treatment of transthyretin amyloid cardiomyopathy - Answer - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardiology MCQ - Treatment of transthyretin amyloid cardiomyopathy - Answer - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"Cardiology MCQ &#8211; Treatment of transthyretin amyloid cardiomyopathy &#8211; Answer Recently developed pharmacotherapy which has been shown to halt and reverse the progression of transthyretin amyloid cardiomyopathy: Correct answer: 2. Tafamidis&nbsp; Transthyretin amyloid cardiomyopathy is due to transthyretin amyloid fibril deposition in the myocardium. Tafamidis acts by binding to transthyretin and prevents tetramer dissociation, thus [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2019-12-14T01:00:00+00:00\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Cardiology MCQ &#8211; Treatment of transthyretin amyloid cardiomyopathy &#8211; Answer\",\"datePublished\":\"2019-12-14T01:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\\\/\"},\"wordCount\":133,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"articleSection\":[\"Cardiology MCQ\",\"DM \\\/ DNB Cardiology Entrance\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\\\/\",\"name\":\"Cardiology MCQ - Treatment of transthyretin amyloid cardiomyopathy - Answer - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2019-12-14T01:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\\\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardiology MCQ &#8211; Treatment of transthyretin amyloid cardiomyopathy &#8211; Answer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardiology MCQ - Treatment of transthyretin amyloid cardiomyopathy - Answer - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/","og_locale":"en_US","og_type":"article","og_title":"Cardiology MCQ - Treatment of transthyretin amyloid cardiomyopathy - Answer - All About Cardiovascular System and Disorders","og_description":"Cardiology MCQ &#8211; Treatment of transthyretin amyloid cardiomyopathy &#8211; Answer Recently developed pharmacotherapy which has been shown to halt and reverse the progression of transthyretin amyloid cardiomyopathy: Correct answer: 2. Tafamidis&nbsp; Transthyretin amyloid cardiomyopathy is due to transthyretin amyloid fibril deposition in the myocardium. Tafamidis acts by binding to transthyretin and prevents tetramer dissociation, thus [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2019-12-14T01:00:00+00:00","author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Cardiology MCQ &#8211; Treatment of transthyretin amyloid cardiomyopathy &#8211; Answer","datePublished":"2019-12-14T01:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/"},"wordCount":133,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/#primaryimage"},"thumbnailUrl":"","articleSection":["Cardiology MCQ","DM \/ DNB Cardiology Entrance"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/","url":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/","name":"Cardiology MCQ - Treatment of transthyretin amyloid cardiomyopathy - Answer - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/#primaryimage"},"thumbnailUrl":"","datePublished":"2019-12-14T01:00:00+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/cardiology-mcq-treatment-of-transthyretin-amyloid-cardiomyopathy-answer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Cardiology MCQ &#8211; Treatment of transthyretin amyloid cardiomyopathy &#8211; Answer"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/30057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=30057"}],"version-history":[{"count":0,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/30057\/revisions"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=30057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=30057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=30057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}